H Zahir, KS Brown, AG Vandell, M Desai, JF Maa… - Circulation, 2015 - journals.lww.com
Background—The oral factor Xa inhibitor edoxaban has demonstrated safety and efficacy in
stroke prevention in patients with atrial fibrillation and in the treatment and secondary …